Rating: Strong Buy
AbbVie Financial Health
Profitability:8.68/10
✅ AbbVie has better Profitability than 75% of the companies on the Drug Manufacturers industry
Net Margin: 18.16%
✅ AbbVie has better Net Margin than 66.67% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): 51.29%
✅ AbbVie has better ROE (Return on Equity) than 90% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): 1.54%
✅ AbbVie has better ROA (Return on Assets) than 66.67% of the companies on the Drug Manufacturers industry
Operating Efficiency:8.69/10
✅ AbbVie has better Operating Efficiency than 58.33% of the companies on the Drug Manufacturers industry
Operating Margin: 25.16%
✅ AbbVie has better Operating Margin than 58.33% of the companies on the Drug Manufacturers industry
Liquidity:2.96/10
❌ AbbVie has worst Liquidity than 75% of the companies on the Drug Manufacturers industry
Quick Ratio: 0.81
❌ AbbVie has worst Quick Ratio than 75% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.66
✅ AbbVie has better Operating Cash Flow Ratio than 75% of the companies on the Drug Manufacturers industry
Solvency:3.24/10
❌ AbbVie has worst Solvency than 100% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 5.7
❌ AbbVie has worst Debt to Equity Ratio than 91.67% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.66
✅ AbbVie has better Interest Coverage Ratio than 75% of the companies on the Drug Manufacturers industry